We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Scansource
SCSC
$1.15B
| $2.35M | ﹤0.01% |
83,603
-5,045
| -6% | -$150K |
|
1877
Verra Mobility
VRRM
$758M
| $2.35M | ﹤0.01% |
153,000
-11,813
| -7% | -$171K |
|
1878
First Interstate BancSystem
FIBK
$3.59B
| $2.35M | ﹤0.01% |
56,140
-6,099
| -10% | -$281K |
|
|
SWTX
1879
DELISTED
SpringWorks Therapeutics
SWTX
| $2.35M | ﹤0.01% |
28,460
+2,398
| +9% | +$182K |
|
|
AVYA
1880
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $2.34M | ﹤0.01% |
87,032
-8,112
| -9% | -$228K |
|
|
CBB
1881
DELISTED
Cincinnati Bell Inc.
CBB
| $2.33M | ﹤0.01% |
151,080
-450
| -0.3% | -$6.93K |
|
1882
OraSure Technologies
OSUR
$278M
| $2.32M | ﹤0.01% |
229,022
+8,839
| +4% | +$86K |
|
1883
World Acceptance Corp
WRLD
$877M
| $2.32M | ﹤0.01% |
14,469
-1,151
| -7% | -$169K |
|
1884
Phreesia
PHR
$787M
| $2.31M | ﹤0.01% |
37,605
+3,049
| +9% | +$159K |
|
|
OSG
1885
Octave Specialty Group
OSG
$230M
| $2.3M | ﹤0.01% |
146,588
-6,574
| -4% | -$106K |
|
|
TSP
1886
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $2.29M | ﹤0.01% |
+32,216
| New | +$1.39M |
|
1887
Allogene Therapeutics
ALLO
$683M
| $2.29M | ﹤0.01% |
87,830
+26,468
| +43% | +$755K |
|
1888
Rocket Companies
RKT
$38.4B
| $2.29M | ﹤0.01% |
118,301
+16,124
| +16% | +$326K |
|
1889
Koppers
KOP
$957M
| $2.29M | ﹤0.01% |
70,714
+1,616
| +2% | +$54.5K |
|
|
ABTX
1890
DELISTED
Allegiance Bancshares
ABTX
| $2.26M | ﹤0.01% |
58,846
-3,841
| -6% | -$155K |
|
1891
Copa Holdings
CPA
$5.79B
| $2.26M | ﹤0.01% |
29,989
-1,933
| -6% | -$156K |
|
1892
Sinclair Inc
SBGI
$1.06B
| $2.26M | ﹤0.01% |
67,967
-5,118
| -7% | -$166K |
|
|
EVRI
1893
DELISTED
Everi Holdings
EVRI
| $2.26M | ﹤0.01% |
90,495
-30,446
| -25% | -$575K |
|
|
SC
1894
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $2.26M | ﹤0.01% |
62,109
-15,092
| -20% | -$524K |
|
|
TBIO
1895
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $2.25M | ﹤0.01% |
81,740
+6,513
| +9% | +$128K |
|
1896
Repay Holdings
RPAY
$330M
| $2.25M | ﹤0.01% |
93,567
+26,284
| +39% | +$616K |
|
1897
CBIZ
CBZ
$2.96B
| $2.24M | ﹤0.01% |
68,278
-3,802
| -5% | -$127K |
|
1898
Universal Electronics
UEIC
$69.1M
| $2.23M | ﹤0.01% |
45,894
+3,933
| +9% | +$204K |
|
|
SRDX
1899
DELISTED
Surmodics
SRDX
| $2.23M | ﹤0.01% |
41,009
-1,003
| -2% | -$55K |
|
|
CHUY
1900
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $2.22M | ﹤0.01% |
59,603
-6,643
| -10% | -$283K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.